Alector Inc
$ 2.70
5.25%
20 Apr - close price
- Market Cap 283,632,000 USD
- Current Price $ 2.70
- High / Low $ 2.74 / 2.56
- Stock P/E N/A
- Book Value 0.28
- EPS -1.39
- Next Earning Report 2026-05-14
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.25 %
- ROE -1.82 %
- 52 Week High 3.40
- 52 Week Low 0.97
About
Alector, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of neurodegenerative diseases. The company is headquartered in South San Francisco, California.
Analyst Target Price
$2.88
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-03 | 2025-11-06 | 2025-08-07 | 2025-05-06 | 2025-02-25 | 2024-11-05 | 2024-08-07 | 2024-05-08 | 2024-02-27 | 2023-11-07 | 2023-08-03 | 2023-05-04 |
| Reported EPS | -0.34 | -0.34 | -0.3 | -0.41 | -0.02 | -0.43 | -0.4 | -0.38 | -0.49 | -0.53 | 0.02 | -0.55 |
| Estimated EPS | -0.3913 | -0.4 | -0.47 | -0.51 | -0.5443 | -0.53 | -0.5 | -0.51 | -0.77 | -0.66 | -0.82 | -0.76 |
| Surprise | 0.0513 | 0.06 | 0.17 | 0.1 | 0.5243 | 0.1 | 0.1 | 0.13 | 0.28 | 0.13 | 0.84 | 0.21 |
| Surprise Percentage | 13.1101% | 15% | 36.1702% | 19.6078% | 96.3256% | 18.8679% | 20% | 25.4902% | 36.3636% | 19.697% | 102.439% | 27.6316% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-14 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.34 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ALEC
2026-04-17 21:39:53
Alector, Inc.'s principal accounting officer, Grace Wong-Sarad, reported an open-market sale of 1,820 shares of common stock at $2.65 per share. This transaction was carried out under a pre-arranged Rule 10b5-1 Trading Plan. Following the sale, Grace Wong-Sarad directly holds 104,645 shares of Alector common stock.
2026-04-17 21:39:53
Grace Wong-Sarad, Principal Accounting Officer at Alector, Inc. (NASDAQ:ALEC), sold 1,820 shares of common stock for $4,823 at a price of $2.65 per share on April 16, 2026, under a Rule 10b5-1 trading plan. The sale occurred while the stock traded below InvestingPro’s Fair Value estimate, despite a 177% gain over the past year. Concurrently, Alector Inc. received an upgrade from BTIG to a Buy rating with a $6.00 price target due to its strategic shift towards developing therapeutics with blood-brain barrier shuttle domains.
2026-04-17 17:34:00
Grace Wong-Sarad, Principal Accounting Officer at Alector, Inc. (NASDAQ:ALEC), sold 1,820 shares of common stock for a total of $4,823. This transaction, executed under a Rule 10b5-1 trading plan, leaves Wong-Sarad with 104,645 shares directly owned. The sale comes as the stock trades below its InvestingPro’s Fair Value estimate, despite a significant 177% gain over the past year.
2026-04-17 01:09:14
Grace Wong-Sarad, Principal Accounting Officer at Alector, Inc. (NASDAQ:ALEC), sold 1,820 shares of common stock for a total of $4823 on April 16, 2026, under a Rule 10b5-1 trading plan. The sale occurred while the stock traded at $2.57, following a 177% gain over the past year. This transaction follows a recent upgrade of Alector Inc. to a Buy rating by BTIG, with a $6.00 price target, due to the company's strategic shift toward developing therapeutics with blood-brain barrier shuttle domains.
2026-04-16 20:09:51
Alector, Inc. (NASDAQ: ALEC) filed a Form 144, reporting proposed and recent common stock sales by an affiliate. The filing details restricted share issuances in March and June 2025, and multiple dispositions by Grace Wong-Sarad in February and March 2026, including 8,071 shares on March 2, 2026, and 3,367 shares on March 3, 2026. This activity is a routine regulatory notice for selling restricted or control securities.
2026-04-16 06:09:17
The article indicates that Alector's stock is performing well due to an upgrade from Cantor Fitzgerald. The upgrade is attributed to Alector's brain carrier platform. No further details are provided in the content.
